Halozyme Makes $2.1B Bid for Evotec, Seeking to Diversify Beyond Enhanze
Drug delivery specialist Halozyme Therapeutics has launched a $2.1 billion (€2 billion) takeover bid for Evotec, a leading drug discovery ...
Tag: Halozyme
Popular Stories
-
Cybin Inc: The Psychedelic Revolution in Mental Health Treatment is Here
-
Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs
-
Aeroplan Status Calculator
-
BlackRock Bitcoin ETF Sees Rally: What’s Next for IBIT?
-
Universal Digital Inc. (Formerly Minas Metals Ltd.) Announces Completion of Change of Business
Small Cap Bulls is your trusted source for uncovering small-cap companies on the brink of explosive growth. With in-depth analysis and expert insights, we help investors navigate the dynamic world of small-cap stocks. Join us as we charge ahead, empowering your investment journey.
2024 Small Cap Bulls – Charging Ahead. All Rights Reserved.
By using this site you agree to the Terms of Use, Privacy Policy, and Service Agreement.
Navigate
stay connected
Join our newsletter